Abiopharma

RenovoRx to Participate in AlphaNorth Capital Event, January 16-18, 2026

New Form 424B5 - SciSparc Ltd. Filed: 2026-01-14 AccNo: 0001213900-26-004172 Size: 316 KB

Air Products to Broadcast Fiscal 2026 First Quarter Earnings Teleconference on January 30, 2026

Director Feinberg Peter 🟢 acquired 20.0K shares of Immuneering Corp (IMRX) at $4.35 Transaction Date: Jan 12, 2026 | Filing ID: 000008

Aurora Achieves Significant Progress in Disease Resistance Research

(99% Neutral) Establishment Labs Holdings Inc (ESTA) Files Form 8-K

Integer Holdings Corporation - Integer to Showcase Innovations in Neuromodulation, Miniaturized Active Implantable Device Technology During NANS 2026 Annual Meeting

(10% Negative) RAPT Therapeutics Inc (RAPT) Announces Delay in opportunity Trials for ozureprubart Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

Ascend Wellness Holdings Announces Opening of New Dispensary in Englewood, Expanding Ohio Footprint

Emergent BioSolutions Receives U.S. FDA Approval on Supplemental New Drug Application for NARCAN® Nasal Spray to be Packaged in a New Carrying Case, Making Life-Saving Naloxone More Accessible for Everyday Preparedness

(75% Positive) Dentsply Sirona Inc (XRAY) Files Form 8-K

New Form 25-NSE - Lexaria Bioscience Corp. Filed: 2026-01-14 AccNo: 0001354457-26-000039 Size: 3 KB

(85% Positive) AngioDynamics Inc (ANGO) Provides Update on management for future operations

(90% Positive) Incannex Healthcare Ltd (IXHL) Provides Update on million for continued execution

Alto Neuroscience, Inc. - Alto Neuroscience Strengthens Intellectual Property Portfolio with Issuance of New Method-of-Treatment Patent for ALTO-207 in Depression